BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 28660351)

  • 1. Moxifloxacin versus levofloxacin or ciprofloxacin prophylaxis in acute myeloid leukemia patients receiving chemotherapy.
    Przybylski DJ; Reeves DJ
    Support Care Cancer; 2017 Dec; 25(12):3715-3721. PubMed ID: 28660351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moxifloxacin versus levofloxacin for antibacterial prophylaxis in acute leukemia patients.
    Lee P; Knoebel RW; Pisano J; Pettit NN
    J Oncol Pharm Pract; 2019 Apr; 25(3):758-761. PubMed ID: 29310512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of antibiotic prophylaxis with cotrimoxazole/colistin (COT/COL) versus ciprofloxacin (CIP) in patients with acute myeloid leukemia.
    Mayer K; Hahn-Ast C; Mückter S; Schmitz A; Krause S; Felder L; Bekeredjian-Ding I; Molitor E; Brossart P; von Lilienfeld-Toal M
    Support Care Cancer; 2015 May; 23(5):1321-9. PubMed ID: 25617073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levofloxacin for febrile neutropenia prophylaxis in acute myeloid leukemia patients associated with reduction in hospital admissions.
    Lee SSF; Fulford AE; Quinn MA; Seabrook J; Rajakumar I
    Support Care Cancer; 2018 May; 26(5):1499-1504. PubMed ID: 29170868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis of neutropenic fever with ciprofloxacin in patients with acute myeloid leukemia treated with intensive chemotherapy.
    Ghadiany M; Rahimi H; Rezvani H; Mohammad Alizadeh A; Zamani N; Mehdizadeh M; Foratyazdi M
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):e11-5. PubMed ID: 24330539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of antibacterial prophylaxis during reinduction chemotherapy for relapse/refractory acute myeloid leukemia.
    Ganti BR; Marini BL; Nagel J; Bixby D; Perissinotti AJ
    Support Care Cancer; 2017 Feb; 25(2):541-547. PubMed ID: 27738797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Levofloxacin Prophylaxis on Bacteremia in Children With Acute Leukemia or Undergoing Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial.
    Alexander S; Fisher BT; Gaur AH; Dvorak CC; Villa Luna D; Dang H; Chen L; Green M; Nieder ML; Fisher B; Bailey LC; Wiernikowski J; Sung L;
    JAMA; 2018 Sep; 320(10):995-1004. PubMed ID: 30208456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciprofloxacin versus colistin prophylaxis during neutropenia in acute myeloid leukemia: two parallel patient cohorts treated in a single center.
    Pohlen M; Marx J; Mellmann A; Becker K; Mesters RM; Mikesch JH; Schliemann C; Lenz G; Müller-Tidow C; Büchner T; Krug U; Stelljes M; Karch H; Peters G; Gerth HU; Görlich D; Berdel WE
    Haematologica; 2016 Oct; 101(10):1208-1215. PubMed ID: 27470601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of levofloxacin and oral third-generation cephalosporins as antibacterial prophylaxis in acute leukaemia patients during chemotherapy-induced neutropenia.
    Yemm KE; Barreto JN; Mara KC; Dierkhising RA; Gangat N; Tosh PK
    J Antimicrob Chemother; 2018 Jan; 73(1):204-211. PubMed ID: 29040595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis.
    De Rosa FG; Motta I; Audisio E; Frairia C; Busca A; Di Perri G; Marmont F
    BMC Infect Dis; 2013 Dec; 13():563. PubMed ID: 24289496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of severe dysglycemia among diabetic patients receiving levofloxacin, ciprofloxacin, or moxifloxacin in Taiwan.
    Chou HW; Wang JL; Chang CH; Lee JJ; Shau WY; Lai MS
    Clin Infect Dis; 2013 Oct; 57(7):971-80. PubMed ID: 23948133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of garenoxacin with levofloxacin as antimicrobial prophylaxis in acute myeloid leukemia.
    Uni M; Yoshimi A; Yamazaki S; Taoka K; Shinohara A; Nannya Y; Nakamura F; Kurokawa M
    Jpn J Clin Oncol; 2015 Aug; 45(8):745-8. PubMed ID: 25989991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Levofloxacin prophylaxis in neutropenic patients].
    Carena AA; Jorge L; Bonvehí P; Temporiti E; Zárate MS; Herrera F
    Medicina (B Aires); 2016; 76(5):295-303. PubMed ID: 27723617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moxifloxacin prophylaxis in neutropenic patients.
    von Baum H; Sigge A; Bommer M; Kern WV; Marre R; Döhner H; Kern P; Reuter S
    J Antimicrob Chemother; 2006 Oct; 58(4):891-4. PubMed ID: 16880172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ciprofloxacin vs. levofloxacin for prophylaxis in recipients of hematopoietic stem cell transplantation.
    Rambaran KA; Seifert CF
    J Oncol Pharm Pract; 2019 Jun; 25(4):884-890. PubMed ID: 30041584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions.
    Leibovici L; Paul M; Cullen M; Bucaneve G; Gafter-Gvili A; Fraser A; Kern WV
    Cancer; 2006 Oct; 107(8):1743-51. PubMed ID: 16977651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fluoroquinolone prophylaxis utility during chemotherapy-induced severe neutropenia in patients with acute leukemia, with fluoroquinolone resistance high prevalence, in a reference hospital in Mexico City].
    Ugarte-Torres A; Villasis-Keever A; Hernández-Bribiesca ME; Crespo-Solis E; Ruiz-Palacios GM; Sifuentes-Osornio J; Ponce-De-León-Garduño A
    Rev Invest Clin; 2006; 58(6):547-54. PubMed ID: 17432285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levofloxacin vs. ciprofloxacin plus phenethicillin for the prevention of bacterial infections in patients with haematological malignancies.
    Timmers GJ; Simoons-Smit AM; Leidekker ME; Janssen JJ; Vandenbroucke-Grauls CM; Huijgens PC
    Clin Microbiol Infect; 2007 May; 13(5):497-503. PubMed ID: 17263835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the rates of Clostridium difficile and bacteremia after delaying fluoroquinolone prophylaxis from day 0 to day +3 post autologous stem cell transplantation.
    Koseck K; Steinberg A; Caliendo G; Meyer J; Kim SS
    Transpl Infect Dis; 2017 Aug; 19(4):. PubMed ID: 28456140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-agent, broad-spectrum fluoroquinolones for the outpatient treatment of low-risk febrile neutropenia.
    Cooper MR; Durand CR; Beaulac MT; Steinberg M
    Ann Pharmacother; 2011 Sep; 45(9):1094-102. PubMed ID: 21862714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.